Lees Pharmaceutical Holdings Probability of Future Pink Sheet Price Finishing Over 1.25E-4

LPCUFDelisted Stock  USD 0.0001  0.00  0.00%   
Lees Pharmaceutical's future price is the expected price of Lees Pharmaceutical instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Lees Pharmaceutical Holdings performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
  
Please specify Lees Pharmaceutical's target price for which you would like Lees Pharmaceutical odds to be computed.

Lees Pharmaceutical Target Price Odds to finish over 1.25E-4

The tendency of Lees Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 0.0001  or more in 90 days
 0.0001 90 days 0.0001 
about 39.65
Based on a normal probability distribution, the odds of Lees Pharmaceutical to move over $ 0.0001  or more in 90 days from now is about 39.65 (This Lees Pharmaceutical Holdings probability density function shows the probability of Lees Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Lees Pharmaceutical price to stay between its current price of $ 0.0001  and $ 0.0001  at the end of the 90-day period is near 1 .
Assuming the 90 days horizon Lees Pharmaceutical has a beta of 0.39. This indicates as returns on the market go up, Lees Pharmaceutical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Lees Pharmaceutical Holdings will be expected to be much smaller as well. Additionally Lees Pharmaceutical Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Lees Pharmaceutical Price Density   
       Price  

Predictive Modules for Lees Pharmaceutical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lees Pharmaceutical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lees Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.00-0.0020.00
Details

Lees Pharmaceutical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Lees Pharmaceutical is not an exception. The market had few large corrections towards the Lees Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Lees Pharmaceutical Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Lees Pharmaceutical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-1.55
β
Beta against Dow Jones0.39
σ
Overall volatility
0
Ir
Information ratio -0.13

Lees Pharmaceutical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lees Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lees Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Lees Pharmaceutical is not yet fully synchronised with the market data
Lees Pharmaceutical has some characteristics of a very speculative penny stock
Lees Pharmaceutical has a very high chance of going through financial distress in the upcoming years
About 64.0% of the company outstanding shares are owned by corporate insiders

Lees Pharmaceutical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Lees Pink Sheet often depends not only on the future outlook of the current and potential Lees Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lees Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding588.8 M

Lees Pharmaceutical Technical Analysis

Lees Pharmaceutical's future price can be derived by breaking down and analyzing its technical indicators over time. Lees Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lees Pharmaceutical Holdings. In general, you should focus on analyzing Lees Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Lees Pharmaceutical Predictive Forecast Models

Lees Pharmaceutical's time-series forecasting models is one of many Lees Pharmaceutical's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Lees Pharmaceutical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Lees Pharmaceutical

Checking the ongoing alerts about Lees Pharmaceutical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Lees Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Lees Pharmaceutical is not yet fully synchronised with the market data
Lees Pharmaceutical has some characteristics of a very speculative penny stock
Lees Pharmaceutical has a very high chance of going through financial distress in the upcoming years
About 64.0% of the company outstanding shares are owned by corporate insiders
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Lees Pink Sheet

If you are still planning to invest in Lees Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lees Pharmaceutical's history and understand the potential risks before investing.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance